Better Decisions

Find out which events are the best for you and your team to attend

Go to Lodescore

Intelligence & Account Based Marketing

Profile companies, people, and topics with data on presentations, posters, sponsors and exhibitors

Go to Lodescore Analytics

Improve ROI

Access live dashboards for spend, savings, budget planning, and ROI measurements

See more

Did you know?

Each year in the United States there are an estimated 1.8 million conventions, conferences, trade shows, and exhibition meetings. In 2015, these events are estimated to attract 247 million participants with an estimated direct spending of $298 billion. When combined with other indirect effects, the conference industry contributes $393 billion annually to US GDP; estimates put this figure at over $1 trillion globally.

With all of the individual and company activities that happen at conferences, they are a rich data resource that can be used for business intelligence and pro-actively monitoring movements within a sector – from scientific innovation, to product launches, to new partnerships/relationships, to trending topics and new perspectives from thought leaders and domain experts. Private equity firms, investment banks, business development professionals, consulting groups, and academic institutions attend conferences to gather information to influence decisions tied to stock and portfolio investments, mergers and acquisitions, identification of new customers, and the development of new products and services.

Recent Posts

Forces for Change

Forces for Change High drug prices, a failing public image, generics-friendly legislation, and a dearth of innovation are forcing M&As, outsourcing, and radical thinking for Pharma.  PBMs are being called to the table for their drug pricing margins. And, get out your glow sticks, because SXSW is the new frontier for Pharma and Tech match-making. […]

Continue reading

Healthcare Fake News

“I want to Believe” was a poster above Fox Mulder’s desk in the paranormal television series, The X-Files. It’s human nature to want to believe; especially at the intersection of health, innovation, and technology. Fans, investors, advocates, and even journalists have been blind-sided by their own failure to ask questions. Billions lost. Just look at a […]

Continue reading

Healthcare and Pharma House of Cards

The United States is twisted in knots over healthcare coverage, access, and costs. Medicaid and Medicare are in the cross-fire. It’s anyone’s guess about how it will all sort itself out and if there will be a ripple effect on how other countries manage their health and payer systems. The bright spot is with real […]

Continue reading